Geoffrey Martha - Jul 29, 2022 Form 4 Insider Report for Medtronic plc (MDT)

Role
Chairman and CEO, Director
Signature
/s/ Thomas L. Osteraas, attorney-in-fact
Stock symbol
MDT
Transactions as of
Jul 29, 2022
Transactions value $
$0
Form type
4
Date filed
8/2/2022, 05:18 PM
Previous filing
Aug 26, 2021
Next filing
Aug 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MDT Ordinary Shares Disposed to Issuer $0 -23.4K -24.03% $0.00 74K Jul 29, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of performance-vesting restricted stock granted in July 2019 and earned dividend equivalent units that have been forfeited based on the Company's failure to meet the cumulative three year non-GAAP diluted earnings per share ("EPS") growth performance target.
F2 This balance increased by 1,600 shares due to exempt acquisitions through dividend reinvestment.